These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11359403)

  • 21. Meningococcal meningitis in a women with inherited deficiency of the ninth component of complement.
    Fine DP; Gewurz H; Griffiss M; Lint TF
    Clin Immunol Immunopathol; 1983 Sep; 28(3):413-7. PubMed ID: 6883811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The occurrence of precipitating antibodies in transfused Japanese patients with hereditary ninth component of complement deficiency and frequency of C9 deficiency.
    Inaba S; Okochi K; Fukada K; Kinoshita S; Maeda Y; Yoshinari M
    Transfusion; 1987; 27(6):475-7. PubMed ID: 3686657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis.
    Kissel JT; Halterman RK; Rammohan KW; Mendell JR
    Arch Neurol; 1991 Jan; 48(1):26-30. PubMed ID: 1986724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP; Imagawa DK; Dankert JR; Ramm LE
    J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The association between deficiency of terminal complement components and the occurrence of meningococcal meningitis].
    Nishizaki M
    Fukuoka Igaku Zasshi; 1992 May; 83(5):201-8. PubMed ID: 1612549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of C9 in complement-mediated killing of Neisseria.
    Harriman GR; Esser AF; Podack ER; Wunderlich AC; Braude AI; Lint TF; Curd JG
    J Immunol; 1981 Dec; 127(6):2386-90. PubMed ID: 6795273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in the genetic basis of human complement C9 deficiency.
    Witzel-Schlömp K; Hobart MJ; Fernie BA; Orren A; Würzner R; Rittner C; Kaufmann T; Schneider PM
    Immunogenetics; 1998 Jul; 48(2):144-7. PubMed ID: 9634479
    [No Abstract]   [Full Text] [Related]  

  • 28. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
    J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microvascular deposition of complement membrane attack complex in dermatomyositis.
    Kissel JT; Mendell JR; Rammohan KW
    N Engl J Med; 1986 Feb; 314(6):329-34. PubMed ID: 3945256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic detection of the silent allele (*Q0) in hereditary deficiencies of the human complement C6, C7, and C9 components.
    Alvarez V; Coto E; Setién F; Spath PJ; López-Larrea C
    Am J Med Genet; 1995 Feb; 55(4):408-13. PubMed ID: 7762578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-incidence of C9 deficiency throughout Japan: there are no significant differences in incidence among eight areas of Japan.
    Hayama K; Sugai N; Tanaka S; Lee S; Kikuchi H; Ito J; Suzuki J; Nagata Y; Kondo H; Harayama O
    Int Arch Allergy Appl Immunol; 1989; 90(4):400-4. PubMed ID: 2613346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization and expression analysis of complement component C9 gene in the whitespotted bambooshark, Chiloscyllium plagiosum.
    Wang Y; Xu S; Su Y; Ye B; Hua Z
    Fish Shellfish Immunol; 2013 Aug; 35(2):599-606. PubMed ID: 23684808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ninth component of human complement: purification and physicochemical characterization.
    Biesecker G; Müller-Eberhard HJ
    J Immunol; 1980 Mar; 124(3):1291-6. PubMed ID: 6766971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High incidence of complement C9 deficiency in Koreans.
    Kang HJ; Kim HS; Lee YK; Cho HC
    Ann Clin Lab Sci; 2005; 35(2):144-8. PubMed ID: 15943177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9.
    Taylor RP; Lindorfer MA; Cook EM; Beurskens FJ; Schuurman J; Parren PWHI; Zent CS; VanDerMeid KR; Burack R; Mizuno M; Morgan BP
    Clin Immunol; 2017 Aug; 181():24-28. PubMed ID: 28578024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLE-like and sicca symptoms in late component (C9) complement deficiency.
    Sugimoto M; Nishikai M; Sato A; Suzuki Y; Nihei M; Uchida J; Mimura N
    Ann Rheum Dis; 1987 Feb; 46(2):153-5. PubMed ID: 3827337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement levels in dogs with familial canine dermatomyositis.
    Hargis AM; Winkelstein JA; Moore MP; Weidner JP; Prieur DJ
    Vet Immunol Immunopathol; 1988 Dec; 20(1):95-100. PubMed ID: 3238922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.